Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

61.00
Delayed Data
As of Apr 29
 -0.20 / -0.33%
Today’s Change
45.45
Today|||52-Week Range
71.60
+2.97%
Year-to-Date

Today’s Trading

Previous close61.20
Today’s open61.03
Day’s range60.48 - 61.45
Volume13,052,698
Average volume (3 months)8,133,490
Market cap$99.0B
Dividend yield3.74%
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+184.55%
Earnings growth (this year)+15.79%
Earnings growth (next 5 years)+14.40%
Revenue growth (last year)+14.52%
P/E ratio19.4
Price/Sales4.24
Price/Book24.97

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.45-1.04%
NVONovo Nordisk-0.25-0.45%
AGNAllergan-2.29-1.05%
SNYSanofi-1.75-4.08%
Data as of 4:01pm ET, 04/29/2016

Financials

Next reporting dateJuly 22, 2016
EPS forecast (this quarter)$1.22
Annual revenue (last year)$22.9B
Annual profit (last year)$5.1B
Net profit margin22.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts

Partner Offers

Search for Jobs